INSMED Inc — Director's Dealing 2021

Sep 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2021-09-07

Reporting Person: SORIANO JOHN (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-07	Common Stock	M	17349	$13.91	Acquired	52553	Direct
2021-09-07	Common Stock	S	17349	$28.2	Disposed	35204	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-07	Stock Option (right to buy)	$13.91	M	17349	Disposed	2029-01-03	Common Stock (17349)	Direct

Footnotes

F1: This is the weighted average sales price representing the shares sold at prices ranging from $28.11 to $28.37 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F2: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.